• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子洞察趋化因子及其同源 G 蛋白偶联受体的激酶介导信号通路。

Molecular insights into kinase mediated signaling pathways of chemokines and their cognate G protein coupled receptors.

机构信息

Department of Biotechnology, Indian Institute of Technology Roorkee (IIT-Roorkee), Roorkee -247667, Uttarakhand, India.

Department of Biotechnology, Indian Institute of Technology Roorkee (IIT-Roorkee), Roorkee -247667, Uttarakhand, India,

出版信息

Front Biosci (Landmark Ed). 2020 Mar 1;25(7):1361-1385. doi: 10.2741/4860.

DOI:10.2741/4860
PMID:32114437
Abstract

Chemokines are small regulatory proteins that play a crucial role in the coordinated migration of cell populations to the site of infection/inflammation by binding to their cognate receptors. In principle, chemokine receptors, which are serpentine G protein-coupled receptors (GPCRs), mediate the series of downstream intracellular signaling events that occur inside the cells to resolve the pathogenicity. Intracellular signaling pathways regulated by the kinase protein sub-families are the center of attention for chemokine derived functional responses. Kinases potentially influence cell migration, cell growth, transcriptional activation, and other essential molecular events. The regulation and flow of the signals by the kinases are different for each physiological and pathological event and are tightly regulated by the nature and pairing of chemokine(s) with its receptor(s). For example, phosphoinositide 3-kinase (PI3K) is activated during the initial steps of the chemokine induced signaling cascade to regulate chemotaxis, transcription, and cell survival. G protein-coupled receptor kinase (GRKs) plays a crucial role in the desensitization and internalization of the chemokine receptors. The regulation of chemokine receptor is also governed by kinases like protein kinase A (PKA), protein kinase C (PKC), mitogen-activated protein kinases / extracellular signal-regulated kinases (MAPK/ERK), . It was also established that tyrosine-protein kinases (TECs) such as ITK and RLK play a significant role in chemokine signaling in T lymphocytes. On a similar note, many others like janus kinases (JAKs), Protein kinase B (PKB), PKC, etc. are also studied in chemokine mediated disease models. The present review elucidates the role of different kinases involved in the chemokine/chemokine receptor mediated signaling cascade during various pathophysiological processes.

摘要

趋化因子是小的调节蛋白,通过与同源受体结合,在细胞群体向感染/炎症部位的协调迁移中发挥关键作用。原则上,趋化因子受体是蛇形 G 蛋白偶联受体 (GPCR),介导细胞内发生的一系列下游细胞内信号事件,以解决致病性。由激酶蛋白亚家族调节的细胞内信号通路是趋化因子衍生的功能反应的关注中心。激酶可能影响细胞迁移、细胞生长、转录激活和其他基本分子事件。激酶对信号的调节和流动因每种生理和病理事件而异,并受趋化因子与其受体的性质和配对的紧密调节。例如,磷酸肌醇 3-激酶 (PI3K) 在趋化因子诱导的信号级联的初始步骤中被激活,以调节趋化性、转录和细胞存活。G 蛋白偶联受体激酶 (GRK) 在趋化因子受体的脱敏和内化中发挥关键作用。趋化因子受体的调节也受蛋白激酶 A (PKA)、蛋白激酶 C (PKC)、丝裂原活化蛋白激酶/细胞外信号调节激酶 (MAPK/ERK) 等激酶的调控。还已经确定酪氨酸蛋白激酶 (TEC),如 ITK 和 RLK,在 T 淋巴细胞中的趋化因子信号转导中发挥重要作用。同样,许多其他激酶,如 Janus 激酶 (JAK)、蛋白激酶 B (PKB)、PKC 等,也在趋化因子介导的疾病模型中进行了研究。本综述阐明了不同激酶在各种病理生理过程中趋化因子/趋化因子受体介导的信号级联中的作用。

相似文献

1
Molecular insights into kinase mediated signaling pathways of chemokines and their cognate G protein coupled receptors.分子洞察趋化因子及其同源 G 蛋白偶联受体的激酶介导信号通路。
Front Biosci (Landmark Ed). 2020 Mar 1;25(7):1361-1385. doi: 10.2741/4860.
2
Chemokines and other GPCR ligands synergize in receptor-mediated migration of monocyte-derived immature and mature dendritic cells.趋化因子和其他 G 蛋白偶联受体配体在单核细胞来源的未成熟和成熟树突状细胞的受体介导迁移中协同作用。
Immunobiology. 2014 Mar;219(3):218-29. doi: 10.1016/j.imbio.2013.10.004. Epub 2013 Oct 14.
3
Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways.《中性粒细胞细胞表面受体及其细胞内信号转导途径》重印版
Int Immunopharmacol. 2013 Dec;17(4):1185-97. doi: 10.1016/j.intimp.2013.11.010. Epub 2013 Nov 18.
4
Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1, -2, -3 and -4.白细胞趋化性:单核细胞趋化蛋白-1、-2、-3和-4对丝裂原活化蛋白激酶和磷脂酰肌醇3激酶激活的检测
Clin Exp Immunol. 2002 Mar;127(3):436-44. doi: 10.1046/j.1365-2249.2002.01764.x.
5
Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.CC趋化因子受体1调控通路的差异趋化因子激活:Gα14偶联通路的配体选择性激活
Eur J Immunol. 2004 Mar;34(3):785-795. doi: 10.1002/eji.200324166.
6
Requirement for Tec kinases in chemokine-induced migration and activation of Cdc42 and Rac.趋化因子诱导的Cdc42和Rac迁移及激活过程中对Tec激酶的需求
Curr Biol. 2004 May 25;14(10):917-22. doi: 10.1016/j.cub.2004.04.011.
7
Signaling events following chemokine receptor ligation in human dendritic cells at different developmental stages.人树突状细胞在不同发育阶段趋化因子受体连接后的信号传导事件。
Int Immunol. 2001 Feb;13(2):167-79. doi: 10.1093/intimm/13.2.167.
8
Kaposi's sarcoma-associated herpesvirus-encoded G protein-coupled receptor activation of c-jun amino-terminal kinase/stress-activated protein kinase and lyn kinase is mediated by related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2.卡波西肉瘤相关疱疹病毒编码的G蛋白偶联受体对c-jun氨基末端激酶/应激激活蛋白激酶和Lyn激酶的激活是由相关黏附斑酪氨酸激酶/富含脯氨酸的酪氨酸激酶2介导的。
J Biol Chem. 1999 Nov 5;274(45):31863-7. doi: 10.1074/jbc.274.45.31863.
9
Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes.脂质磷酸酶SHIP对淋巴细胞趋化因子受体信号传导的异源调节
Cell Signal. 2005 Oct;17(10):1194-202. doi: 10.1016/j.cellsig.2004.12.009.
10
CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase.人T细胞的CXCR3介导的趋化作用由Gi和磷脂酶C依赖性途径调节,而非通过MEK/p44/p42丝裂原活化蛋白激酶或Akt/PI-3激酶的激活来调节。
Blood. 2003 Sep 15;102(6):1959-65. doi: 10.1182/blood-2002-12-3945. Epub 2003 May 15.

引用本文的文献

1
The Improvement of Intestinal Mucosal Epithelial Barrier Integrity by 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-]pyridazinone in Rat Experimental Colitis.吡咯并[3,4 - ]哒嗪酮的1,3,4 - 恶二唑衍生物对大鼠实验性结肠炎肠黏膜上皮屏障完整性的改善作用
J Inflamm Res. 2025 Jul 22;18:9735-9753. doi: 10.2147/JIR.S527041. eCollection 2025.
2
Targeting the chemokine receptor CXCR4 for cancer therapies.以趋化因子受体CXCR4为靶点进行癌症治疗。
Biomark Res. 2025 May 1;13(1):68. doi: 10.1186/s40364-025-00778-y.
3
Protein Kinases as Mediators for miRNA Modulation of Neuropathic Pain.
蛋白激酶作为微小RNA调节神经性疼痛的介质
Cells. 2025 Apr 11;14(8):577. doi: 10.3390/cells14080577.
4
Pro-Inflammatory Cytokines Transactivate Glycosylated Cytokine Receptors on Cancer Cells to Induce Epithelial-Mesenchymal Transition to the Metastatic Phenotype.促炎细胞因子通过反式激活癌细胞上的糖基化细胞因子受体,诱导上皮-间质转化,形成转移表型。
Cancers (Basel). 2025 Apr 5;17(7):1234. doi: 10.3390/cancers17071234.
5
Chemokine-mediated F-actin dynamics, polarity, and migration in B lymphocytes depend on WNK1 signaling.趋化因子介导线粒体 F-肌动蛋白动态、极性和 B 淋巴细胞迁移依赖于 WNK1 信号通路。
Sci Signal. 2024 Aug 27;17(851):eade1119. doi: 10.1126/scisignal.ade1119.
6
Biopotency and surrogate assays to validate the immunomodulatory potency of extracellular vesicles derived from mesenchymal stem/stromal cells for the treatment of experimental autoimmune uveitis.鉴定间充质干细胞来源的细胞外囊泡的免疫调节效力的生物效价和替代测定法,用于治疗实验性自身免疫性葡萄膜炎。
J Extracell Vesicles. 2024 Aug;13(8):e12497. doi: 10.1002/jev2.12497.
7
CC Chemokine Family Members' Modulation as a Novel Approach for Treating Central Nervous System and Peripheral Nervous System Injury-A Review of Clinical and Experimental Findings.CC 趋化因子家族成员的调节作为治疗中枢神经系统和周围神经系统损伤的新方法——临床和实验研究结果综述。
Int J Mol Sci. 2024 Mar 28;25(7):3788. doi: 10.3390/ijms25073788.
8
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review.当前JAK激酶抑制剂作为抗新冠病毒药物的治疗意义:综述
Front Pharmacol. 2023 Mar 20;14:1135145. doi: 10.3389/fphar.2023.1135145. eCollection 2023.
9
Chemokines and chemokine receptors as promising targets in rheumatoid arthritis.趋化因子及其受体作为类风湿关节炎治疗的潜在靶点
Front Immunol. 2023 Feb 13;14:1100869. doi: 10.3389/fimmu.2023.1100869. eCollection 2023.
10
Recent clinical findings on the role of kinase inhibitors in COVID-19 management.近期关于激酶抑制剂在 COVID-19 管理中作用的临床发现。
Life Sci. 2022 Oct 1;306:120809. doi: 10.1016/j.lfs.2022.120809. Epub 2022 Jul 13.